How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
91
BOW Quote, Financials, Valuation and Earnings
Last price:
$40.65
Seasonality move
:
--
Day range:
$40.69 - $42.29
52-week range:
$17.00 - $42.29
Dividend yield:
0%
P/E ratio:
35.35x
P/S ratio:
3.13x
P/B ratio:
3.72x
Volume:
583.1K
Avg. volume:
284.1K
1-year change:
--
Market cap:
$1.4B
Revenue:
$425.6M
EPS (TTM):
$1.19
Analysts' Opinion
-
Consensus RatingBowhead Specialty Holdings has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $37.20, Bowhead Specialty Holdings has an estimated downside of -11.74% from its current price of $42.15.
-
Price Target UpsideAccording to analysts, the highest upside price target is $44.00 representing -100% upside increase from its current price of $42.15.
Fair Value
-
According to the consensus of 2 analysts, Bowhead Specialty Holdings has -11.74% downside to fair value with a price target of $37.20 per share.
BOW vs. S&P 500
-
Over the past 5 trading days, Bowhead Specialty Holdings has overperformed the S&P 500 by 13.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bowhead Specialty Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bowhead Specialty Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bowhead Specialty Holdings reported revenues of $119.3M.
Earnings Growth
-
Bowhead Specialty Holdings has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Bowhead Specialty Holdings reported earnings per share of $0.41.
Enterprise value:
389.3M
EV / Invested capital:
--
Price / LTM sales:
3.13x
EV / EBIT:
7.59x
EV / Revenue:
0.91x
PEG ratio (5yr expected):
0.90x
EV / Free cash flow:
1.34x
Price / Operating cash flow:
4.57x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.84%
Net Income Margin (TTM):
8.99%
Return On Equity:
13.02%
Return On Invested Capital:
13.02%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | -- | $283.4M | $425.6M | $82.8M | $119.3M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | $0.86 | $1.19 | $0.15 | $0.41 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $721.4M | $1.1B | |
| Total Assets | -- | -- | -- | $1B | $1.7B | |
| Current Liabilities | -- | -- | -- | $55.4M | $71.4M | |
| Total Liabilities | -- | -- | -- | $835.8M | $1.3B | |
| Total Equity | -- | -- | -- | $192.1M | $370.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $236.2M | $294.3M | $61.4M | $61.4M | |
| Cash From Investing | -- | -$274.8M | -$325.9M | -$100.8M | -$1.1M | |
| Cash From Financing | -- | $77.7M | $133.9M | $24.6M | $64K | |
| Free Cash Flow | -- | $232.4M | $291.2M | $60.5M | $60.9M | |
BOW
Sector
Market Cap
$1.4B
$623M
Price % of 52-Week High
99.67%
85.76%
Dividend Yield
0%
1.98%
Shareholder Yield
-11.54%
3.73%
1-Year Price Total Return
--
7.41%
Beta (5-Year)
--
0.714
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$39.66
200-day SMA
Buy
Level
$31.13
Bollinger Bands (100)
Buy
Level
31.85 - 36.63
Chaikin Money Flow
Buy
Level
1.8M
20-day SMA
Buy
Level
$36.63
Relative Strength Index (RSI14)
Buy
Level
77.81
ADX Line
Buy
Level
42.97
Williams %R
Sell
Level
-1.5301
50-day SMA
Buy
Level
$34.20
MACD (12, 26)
Buy
Level
2.08
25-day Aroon Oscillator
Buy
Level
96
On Balance Volume
Neutral
Level
9.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6661)
Sell
CA Score
(Annual)
Level (-1.5014)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (0.9559)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.
Stock Forecast FAQ
In the current month, BOW has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The BOW average analyst price target in the past 3 months is $37.20.
-
Where Will Bowhead Specialty Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bowhead Specialty Holdings share price will drop to $37.20 per share over the next 12 months.
-
What Do Analysts Say About Bowhead Specialty Holdings?
Analysts are divided on their view about Bowhead Specialty Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bowhead Specialty Holdings is a Sell and believe this share price will rise from its current level to $30.00.
-
What Is Bowhead Specialty Holdings's Price Target?
The price target for Bowhead Specialty Holdings over the next 1-year time period is forecast to be $37.20 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is BOW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bowhead Specialty Holdings is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BOW?
You can purchase shares of Bowhead Specialty Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bowhead Specialty Holdings shares.
-
What Is The Bowhead Specialty Holdings Share Price Today?
Bowhead Specialty Holdings was last trading at $40.65 per share. This represents the most recent stock quote for Bowhead Specialty Holdings. Yesterday, Bowhead Specialty Holdings closed at $42.15 per share.
-
How To Buy Bowhead Specialty Holdings Stock Online?
In order to purchase Bowhead Specialty Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
